Ypsomed Holding AG (YPSN)
SIX
Real-time Data
07:00 AM
Day's Range
405.0052 wk Range
260.50Overview - YPSN - Ypsomed Holding AG
Key Statistics
Valuation
Enterprise Value
5.55B
P/E (Trailing)
‪24.87‬
P/E (Forward)
‪26.81‬
PEG Ratio
‪26.81‬
Price / Sales (TTM)
‪7.28‬
Price / Book
‪6.84‬
EV / EBITDA
‪17.05‬
Profitability
Profit Margin
‪30.36%‬
Operating Margin
‪26.45%‬
Return on Assets
‪12.35%‬
Return on Equity
‪31.08%‬
Ownership
Shares Outstanding
13.14M
Float
3.50M
Held by Insiders
‪74.53%‬
Held by Institutions
‪15.45%‬
Price stats
Beta
‪0.76‬
50-Day Avg
‪376.85‬
200-Day Avg
‪325.97‬
Dividends
Payout Ratio
‪13.50%‬
Frequency
Annual
Peers - YPSN - Ypsomed Holding AG
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on SIX.
Profile Summary - YPSN - Ypsomed Holding AG
About
Ypsomed Holding AG is a Swiss multinational medical technology company specializing in the development and manufacturing of injection and infusion systems for self-medication. Headquartered in Burgdorf, Switzerland, it emerged in 2003 from the Disetronic Group and focuses primarily on diabetes care and biotechnology…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
